Motif Bio PLC

Motif Bio to de-list from Nasdaq in the US

It will keep its UK stock market quote and become a cash shell

Motif Bio PLC -
Following the wind-down of its business, Motif Bio will become a cash shell

Motif Bio PLC (LON:MTFB) said it expects to make “significant savings” from delisting its depositary shares from America’s NASDAQ market.

It will remain listed on AIM in the UK. Following the wind-down of its business, Motif Bio will become a cash shell

It expects to file the paperwork in the US on or around December 5, with de-listing coming into effect no less than 10 days later.

Quick facts: Motif Bio PLC

Price: 0.606 GBX

Market: AIM
Market Cap: £2.94 m


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Motif Bio PLC named herein, including the promotion by the Company of Motif Bio PLC in any Content on the Site, the Company receives from said...



Motif Bio's Graham Lumsden updates on FDA discussions and iclaprim potential

Motif Bio PLC's (LON:MTFB) Graham Lumsden chats to Proactive London's Andrew Scott after a meeting earlier this month with Food and Drug Administration officials to chart the next steps to get US regulators to approve their antibiotic iclaprim. Feedback from that meeting is expected in...

on 24/5/19


Holding(s) in Company

2 days, 18 hours ago

Holding(s) in Company

1 week, 3 days ago

Total Voting Rights

1 week, 3 days ago

Holding(s) in Company

2 weeks, 5 days ago

Directorate Changes

3 weeks ago

Result of General Meeting

3 weeks, 4 days ago

2 min read